<h2 class="mt-4 text-lg font-medium text-color-lightgreytext" data-astro-cid-fjd3bvuv>
Summary from the AllSides News Team
</h2> <div class="mt-2 text-md editor-content" data-astro-cid-fjd3bvuv><p>The government's newest rules for which COVID-19 treatments can be used sparked significant backlash from the state of Florida.</p>

<p>The <a href="/news/2022-01-25-0743/fda-closes-monoclonal-antibody-clinics-florida-desantis-seeks-reversal">Food and Drug Administration (FDA) halted monoclonal antibody treatments</a> made by Regeneron and Eli Lilly this week after reporting that they’re "highly unlikely"&nbsp;to work against the now-dominant Omicron variant.&nbsp;In Florida, where multiple monoclonal antibody facilities had been treating patients, Gov. Ron DeSantis condemned the FDA's move as "indefensible," saying&nbsp;it "takes treatment out of the hands of medical professionals." A Monday press release from Florida's Department of Health announced closure of the state's monoclonal antibody treatment sites while citing&nbsp;<a href="https://www.nature.com/articles/s41591-021-01678-y" target="_blank" rel="noopener noreferrer">a study on the National Institutes of Health (NIH) website</a> that says the effectiveness of monoclonal remedies against Omicron "remains to be determined."&nbsp;Before Omicron's rise, the&nbsp;treatments were found to be effective in preventing COVID-19 hospitalizations.</p>

<p>Coverage from left-rated sources often highlighted the FDA's announcement and other health experts who said monoclonal antibody treatments were ineffective against Omicron; few, if any, highlighted experts who opposed the FDA's announcement. Conversely, reports from right-rated sources typically focused more on&nbsp;experts who celebrated the monoclonal treatments and were skeptical of the FDA's move. Many also highlighted the study that suggests more research is needed on how effective monoclonal antibodies are against Omicron. Several voices from left-rated media outlets, such as <a href="/news-source/salon">Salon (Left bias)</a> and <a href="/news-source/washington-post-media-bias">Washington Post (Lean Left)</a>, accused DeSantis of <a href="https://www.washingtonpost.com/opinions/2022/01/26/republicans-like-ron-desantis-keep-kowtowing-maga-cult-even-if-it-threatens-lives/" target="_blank" rel="noopener noreferrer">lying about the effectiveness</a> of the treatments in an attempt to <a href="https://www.salon.com/2022/01/26/what-ron-desantis-fight-with-the-fda-is-really-all-about-donald/" target="_blank" rel="noopener noreferrer">appease</a>&nbsp;anti-vaccine voters.&nbsp;</p>
</div> <h2 class="mb-2 leading-6 text-lg text-gray-500 font-medium mt-4 p-0">
Featured Coverage of this Story
</h2> <div class="flex gap-5 my-2 mb-8 md:flex-row flex-col"> <div class="flex-1 right"><div class="mb-2 font-bold border-solid global-bias-label text-color-right border-b-[3px] text-s border-color-right">From the Right</div><a id="News-Item--experts-divided-on-us-drug-regulators-revoking-authorization-of-key-covid-19-treatments" href="https://www.theepochtimes.com/experts-divided-on-us-drug-regulators-revoking-authorization-of-key-covid-19-treatments_4240214.html?utm_source=partner&utm_campaign=allsides" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">Experts Divided on US Drug Regulators Revoking Authorization of Key COVID-19 Treatments</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">The Epoch Times</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-right.png" alt="AllSides Media Bias Rating: Lean Right" title="AllSides Media Bias Rating: Lean Right" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/monoclonal-administration-700x420.jpg" alt="Experts Divided on US Drug Regulators Revoking Authorization of Key COVID-19 Treatments" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">(Hannah Beier/Reuters)</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>The&nbsp;Food and Drug Administration’s decision to effectively revoke emergency use authorization for two monoclonal antibody treatments has left experts divided, with some calling it the right move and others asserting it shouldn’t have been done.</p><p>The agency, of the FDA, on Jan. 24&nbsp;announced&nbsp;it was barring use of treatments from Eli Lilly and Regeneron anywhere in the country because of federal data that indicate the Omicron virus variant is behind the vast majority of COVID-19 cases.</p><p>The regulator cited “the most recent information and data available” but did not link to...</div><a id="Open-On--the-epoch-times" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.theepochtimes.com/experts-divided-on-us-drug-regulators-revoking-authorization-of-key-covid-19-treatments_4240214.html?utm_source=partner&utm_campaign=allsides" target="_blank" rel="noopener">
Open on The Epoch Times<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a><div class="flex-1 whitespace-nowrap text-gray-500 text-xs leading-4 flex mt-2"><div class="hover:cursor-help" data-tippy-content="<p><span style=&#34;white-space: nowrap;&#34;>Some content from this outlet may be</span><br><span style=&#34;white-space: nowrap;&#34;>limited or behind a paywall.</span></p>"><i class="fa-regular fa-sack-dollar mr-1"></i><span class="whitespace-nowrap">Possible Paywall</span></div></div></div></div><script type="43efed28a01357c67f806051-module" src="/_astro/story-related-news.astro_astro_type_script_index_0_lang.DjPUAy8u.js"></script><div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--desantis-fumes-over-fda-interference" href="https://www.axios.com/local/tampa-bay/2022/01/26/desantis-fumes-over-fed-interference-fda" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">DeSantis fumes over FDA interference</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Axios</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-left.png" alt="AllSides Media Bias Rating: Lean Left" title="AllSides Media Bias Rating: Lean Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/1643154933792.jpg" alt="DeSantis fumes over FDA interference" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Illustration: Annelise Capossela/Axios</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">Analysis</div><div class="[&>p]:my-2 text-sm editor-content"><p>Gov. Ron DeSantis is&nbsp;blasting the Biden administration&nbsp;after the FDA revoked the use of two different monoclonal antibody treatments, forcing Florida to shutter treatment clinics across the state.</p><p>Driving the news:&nbsp;The FDA halted monoclonal antibody cocktails made by Regeneron and Eli Lilly on Monday after finding they’re not effective against the Omicron variant.</p><p>The FDA pointed to&nbsp;CDC statistics showing&nbsp;that Omicron accounted for 99% of COVID-19 cases in the U.S. as of Jan. 15.</p><p>The agency noted that "data show these treatments are highly unlikely to be active" against Omicron, so monoclonal...</div><a id="Open-On--axios" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.axios.com/local/tampa-bay/2022/01/26/desantis-fumes-over-fed-interference-fda" target="_blank" rel="noopener">
Open on Axios<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div><div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--monoclonal-antibodies-were-doing-nothing-against-omicron-that-s-why-fda-pulled-its-authorization-" href="https://www.usatoday.com/story/news/health/2022/01/27/omicron-variant-fda-monoclonal-antibodies-covid/9211114002/" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">Monoclonal antibodies were &#39;doing nothing&#39; against omicron: That&#39;s why FDA pulled its authorization.</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">USA TODAY</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-left.png" alt="AllSides Media Bias Rating: Lean Left" title="AllSides Media Bias Rating: Lean Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/044b3f8c-fc15-4311-80a9-0bd964a1393b-Monoclonal_antibody_injection_Regenerons_REGN-COV.jpg" alt="Monoclonal antibodies were 'doing nothing' against omicron: That's why FDA pulled its authorization." class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">USA TODAY</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">Analysis</div><div class="[&>p]:my-2 text-sm editor-content"><p>The Food and Drug Administration pulled its authorization of two of the most used monoclonal antibodies to treat&nbsp;COVID-19 this week, leaving doctors with fewer options to help their&nbsp;patients avoid the hospital.</p><p>Why did the FDA shut them down?</p><p>Because the two, from drugmakers Regeneron and Eli Lilly, don't work against the omicron variant that&nbsp;now causes more than 99%&nbsp;of coronavirus infections in the United States.</p><p>"All the data show that these older antibodies are ineffective against omicron," said Dr. Daniel Kuritzkes, chief of the division of infectious diseases at Brigham and...</div><a id="Open-On--usa-today" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.usatoday.com/story/news/health/2022/01/27/omicron-variant-fda-monoclonal-antibodies-covid/9211114002/" target="_blank" rel="noopener">
Open on USA TODAY<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a><div class="flex-1 whitespace-nowrap text-gray-500 text-xs leading-4 flex mt-2"><div class="hover:cursor-help" data-tippy-content="<p><span style=&#34;white-space: nowrap;&#34;>Some content from this outlet may be</span><br><span style=&#34;white-space: nowrap;&#34;>limited or behind a paywall.</span></p>"><i class="fa-regular fa-sack-dollar mr-1"></i><span class="whitespace-nowrap">Possible Paywall</span></div></div></div></div> </div> <p class="mt-2 mb-5 text-right"> <a id="More-headline-roundups" class="group relative pr-5 hover:no-underline border-b border-opacity-0 hover:border-opacity-100 border-color-text inline-block w-fit cursor-pointer text-sm no-underline" href="/headline-roundups">